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ABSTRACT

SULFORAPHANE PREVENTS ACETAMINOPHEN-INDUCED HEPATIC INJURY IN MICE

Robin H. Schmidt
11/29/2011

Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is known to
confer antioxidant protection in vivo. Rather than directly reacting with free radicals, however,
SFN works by inducing Nrf2, a transcription factor that binds to the promoter regions of several
known antioxidant genes and enhances detoxification. Because oxidative stress is a major
contributor to acetaminophen (APAP)-induced hepatotoxicity, SFN may defend the liver against
APAP overdose by activating the Nrf2 pathway and increasing endogenous antioxidant response.
To test this hypothesis, mice were pre-treated with SFN for four days, injected with APAP on the
fifth day, and sacrificed shortly thereafter. APAP overdose caused massive hepatic injury, as
shown by increases in serum liver enzyme activity and lipid peroxidation. APAP overdose also
manifested as decreases in total glutathione and glutathione reductase activity. SFN
administration clearly prevented these manifestations of liver injury, however: increases in serum
liver enzyme activity and lipid peroxidation were blunted, while total glutathione and glutathione
reductase activity remained similar to those of control animals. SFN treatment did not affect the
catalytic activity of acetaminophen-metabolizing enzyme CYP2E1, but did increase nuclear
accumulation of Nrf2, suggesting that SFN acts primarily through the Nrf2 pathway. In summary,
these data support the hypothesis that sulforaphane attenuates acute acetaminophen-induced
liver injury. This decrease in injury results from the increased availability of glutathione to react
with toxic metabolites of acetaminophen.
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INTRODUCTION

The byproducts of hepatic drug metabolism are often oxidants or electrophiles which
readily react with important biological moleculesY-3) Under ideal conditions, reactive metabolites
are removed from the liver by a multitude of enzymes that have evolved for this purpose. Yet in
certain situations these metabolites may accumulate. The resulting condition is broadly termed
"oxidative stress" and leads to potentially dangerous alterations in hepatic structure and
function.(4)
Oxidative stress is demonstrably reduced in vitro with direct-acting antioxidants such as
tocopherols and melatonin. In animal and human studies, however, the benefits of antioxidant
use are far less apparent. The reason for this experimental incongruity is still unclear. One
suggestion is that, in whole animal models, it is difficult to achieve adequate antioxidant
concentrations anhe desired site of action. (5; 6) Alpha-tocopherol, for example-;1ends to
accumulate in cellular membranes, and therefore has limited ability to quench reactive molecules
within the cytoplasm. Many free radical-scavenging agents are also hypothesized to act as prooxidants, which may explain the observation that high doses of antioxidant vitamins actually
increase morbidity and mortality. (7-10)
Many researchers are now looking toward the use of indirect antioxidants as a treatment for
oxidative stress. In contrast to direct agents, such as the previously-mentioned antioxidant
vitamins, indirect antioxidants do not interact with reactive metabolites or free radicals. (11)
Sulforaphane (SFN), an isothiocyanate derived from Brassica vegetables, is a prototypical
indirect antioxidant. Rather than reducing reactive metabolites, SFN induces Nrf2, a transcription
factor that regulates cellular defense against toxicity.(12; 13) The proposed mechanism of defense
is an interaction between SFN and Keap1, a substrate adaptor for the E3 ubiquitin ligase CuI3.(14;
15) During homeostasis Nrf2 is 'found in the cytoplasm, where it binds Keap1. In the absence
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of stressors, Nrf2 and Keap1 remain bound, and Keap1 will eventually facilitate proteasomal
degradation of Nrf2. Conversely, if electrophiles or oxidants are present, they will disrupt the
bond between Nrf2 and Keap1, allowing Nrf2 to translocate to the nucleus and bind antioxidant
response elements (AREs) in DNA.(16; 17) In particular, it is the electrophilic central carbon atom
of SFN's -N=C=S side chain which theoretically disrupts the Nrf2-Keap1 bond, as this carbon can
readily form thionoacyl adducts.(lS; 19) Following alkylation, Nrf2 would then be free to bind AREs
which regulate the transcription of genes encoding cytoprotective enzymes, e.g., heme
oxygenase 1 (Fig. 1).
The purpose of the present study was to determine the ability of SFN to prevent toxicity in an
established model of oxidative stress. Acetaminophen (APAP) was chosen because, though it is
safe within its intended dose range, it causes a concentration-dependent and easily reproducible
injury to hepatocytes at larger doses.(20) APAP's toxicity is mediated in part by its oxidative
byproduct NAPQI, which can drastically deplete glutathione reserves.(21; 22) Despite substantial
evidence of SFN's protective properties, there are no FDA-approved therapies for oxidative injury
that incorporate indirect antioxidants. The results presented here further support the need for
indirect antioxidants in clinical practice.
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MATERIALS AND METHODS

Animals and treatments

Male C57BLl6J mice (6-8 weeks old) were purchased from Jackson Laboratory (Bar
Harbor, ME). Mice were housed in a pathogen-free barrier facility accredited by the Association
for Assessment and Accreditation of Laboratory Animal Care, and procedures were approved by
the local Institutional Animal Care and Use Committee. All diets were switched from standard
laboratory chow to AIN-76A purified diet one week prior to the study, since impurities found in
standard laboratory chow may create experimental variability. Food and tap water were allowed
ad libitum.
In experiments designed to test the effects of SFN alone, mice were administered SFN

(10 mg/kg i.g. diluted in water; LKT Laboratories, St. Paul, MN) or water for 4 days q.a.m. Groups
-of mice were selected to be euthanized at six or 24 hours after the last i.g. dOSing. In experiments
designed to test the protective effects of SFN on APAP overdose, mice were administered SFN

(10 mg/kg i.g.) or water for 4 days q.a.m. On the following day, mice were injected with APAP
(300 mg/kg i.p.; Sigma-Aldrich, St. Louis, MO). Six hours after APAP injection (24 h after last i.g.
SFN or water), the mice were euthanized.
Regardless of experimental treatment, procedures used in harvesting tissue were the
same. Mice were euthanized with ketamine/xylazine (100/15 mg/kg i.m.), and their blood and
livers were collected for later analysis. Blood was collected from the vena cava just prior to
sacrifice by exsanguination and citrated plasma was stored at -80°C for later analysis. Portions
of liver tissue were snap-frozen in liquid nitrogen, frozen-fixed in OCT-Compound (Tissue-Tek
OCT compound, Sakura Finetek, Torrance, CA), or fixed in 10% neutral buffered formalin for
subsequent sectioning and mounting on microscope slides. Some snap-frozen liver was
homogenized in 4.4% metaphosphoric acid for detection of glutathione.
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Biochemical analyses and histology
Plasma levels of aminotransferases (AL T) and hepatic levels of triglycerides were
determined using standard kits (Thermotrace, Melbourne, Australia). Paraffin-embedded
sections of liver were stained with hematoxylin & eosin (H&E). Red blood cell extravasation in
the livers was assessed by staining tissue sections for chloroacetate esterase, a marker for
RBCs, using the naphthol AS-D chloroacetate esterase (CAE) kit (Sigma, St. Louis MO).
Adducts of 4-hydroxynonenal (lipid peroxidation) were detected by immunohistochemistry as
described previously.(23)

Quantitation of glutathione content and glutathione reductase activity
Total cellular glutathione content was quantitated colorimetrically from liver samples using a
modified version of the method described by Rahman. (24) A 10% solution of tissue homogenate

(w/v) was prepared in 4.4% meta phosphoric acid using an all-glass Tenbroeck homogenizer, and
kept on ice. After standing for 20-40 min, the homogenate was centrifuged for 1 min (10,000 x

g), and the supernatant collected. Twenty tJl of the supernatant were added to each well of a
microtiter plate and incubated with 120 tJl of a solution containing potassium phosphate buffer
(pH 7.S), 10 mM EDTA, 2 mM S,S'-dithiobis(2-nitrobenzoic acid) (DTNB) and 230 U/mL
glutathione reductase (GR, EC 1.6.4.2, Sigma-Aldrich, St. Louis, MO). After allowing 60 seconds
for conversion of GSSG to GSH, 60 tJl of buffered NADPH solution was added, and the
absorbance was read for S minutes at 412 nm during the linear portion of the reaction. Total
glutathione was calculated from a standard curve prepared with purified GSH. Results were
reported as nmol GSH per g tissue wet weight.
To determine GR activity, liver tissue was homogenized in a phosphate buffer
(pH 7.S) containing 1 mM DTT and centrifuged for 10 min (10,000 x g) to clear the homogenate.
Twenty tJl of each sample were then added to each well of a microtiter plate and incubated for 60
sec with a solution containing phosphate buffer, 2 mM GSSG, and 1 mM NADPH. The
absorbance was read for S min at 412 nm, and enzyme activity was calculated from a standard
curve of purified GR. The protein concentration of the homogenate was subsequently measured
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according to the method of Bradford. (25) After adjusting for protein concentration, glutathione
reductase activity was reported as units of activity/mg protein.

Microsomal isolation and cytochrome P450 activity determination
Expression and activity data were obtained for cytochrome P450 2E1 (CYP2E1), the
microsomal enzyme that generates NAPQI. Microsomes were isolated according to a protocol
adapted from those of COX(26) and Falkner.(27) Briefly, liver tissue was kept on ice and
homogenized with a Teflon pestle in a buffer containing 50 mM Tris-HCI (pH 7.4), 225 mM
mannitol and 75 mM sucrose. The homogenate was spun at 15,000 x 9 for 20 minutes, after
which the supernatant was collected and spun at 436,000 x 9 for an additional 20 min. The pellet
remaining was next resuspended in a buffer of 250 mM mannitol, 0.5 mM EGTA, and 5mM
HEPES (pH 7.4) and centrifuged again at 9,000 x 9 for 30 min. The supernatant resulting from
this centrifugation was collected, assessed for protein concentration, and stored at -SO° until
kinetic analysis.
CYP2E1-mediated conversion of p-nitrophenol to 4-nitrocatechol was measured by
spectrophotometer as described previously. (28; 29) Isolated microsomes were added to each well
of a microtiter plate along with an assay buffer containing 100 mM sodium phosphate (pH 6.S),
0.1 mM p-nitrophenol, and 1mM NADPH. After incubating for 10 min at 37°, the absorbance was
read at 4S0 nm for 12 min and concentration values were interpolated from a standard curve of 4nitrocatechol dissolved in sodium phosphate buffer. Activity was determined from the change in
4-nitrocatechol concentration per unit time.

Immunoblots
All buffers used for protein extraction contained protease, tyrosine phosphatase, and
serine/threonine phosphatase inhibitor cocktails (Sigma, St. Louis, MO).

Nuclear proteins were

isolated according to the method of Dignam et al.(30) A sample of liver tissue (50-100 mg) from
each animal was homogenized in a pre-chilled Dounce glass tissue grinder containing 500 IJL
hypotonic buffer (1.5 mM MgCI 2, 1 mM KCI, .5 mM DTT,10 mM HEPES, pH 7.6). The
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homogenate was placed on ice for 15 minutes, then vigorously mixed with 30 IJl of a 10% NP-40
solution and centrifuged for 30 sec at 16,000 x g. The supernatant (cytosolic fraction) was
transferred to a separate tube and the pellet was mixed with 70 IJl of resuspension buffer (50%
v/v glycerol, 420 mM NaCI, .25 mM EDTA, .5 mM DTT, 10 mM HEPES, pH 7.6). After the
resuspended samples were agitated on ice for 15 min, they were then spun for 5 min at 16,000 x

g, and the supernatant (nuclear fraction) was collected and stored at -80°C.
Nuclear and cytosolic proteins were loaded onto SDS-polyacrylamide gels of 10% (w/v)
acrylamide followed by electrophoresis and Western blotting onto PVDF membranes (Hybond P,
GE Healthcare, Piscataway, NJ). Primary antibodies against Nrf2 and GAPDH (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) were used. Bands were visualized using an ECl kit
(Pierce, Rockford, Il) and Hyperfilm (GE Healthcare, Piscataway, NJ).

RNA isolation and real-time RT-peR

Message levels of select genes were detected by real-time reverse-transcriptase PCR.
Total RNA was extracted from liver tissue samples by a guanidium thiocyanate-based method
(Tel-Test, Austin, TX). RNA concentrations were determined spectrophotometrically, and cDNA
was synthesized from 1 IJg total RNA using an MMlV reverse transcriptase kit (Quanta
Biosciences, Gaithersburg, MD). The cDNA was added to a mixture containing pre-made primers
and probes (Applied Biosystems, Foster City, CA) and a ready-to-use reaction buffer (Quanta).
Amplification reactions were carried out in the StepOne™ sequence detection system (Applied
Biosystems). The comparative CT method was used to determine fold differences between
samples and the calibrator gene, ~-actin.

Statistical analyses

Results are reported as means ± SEM (n

=4-7). ANOVA with Bonferroni's post-hoc test

(for parametric data) or Mann-Whitney Rank Sum test (for non parametric data) was used for the
determination of statistical significance among treatment grou ps, as appropriate. A
than 0.05 was selected before the study as the level of significance.
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p value less

RESULTS

SFN treatment protected mice from necrosis caused by APAP
Elevated plasma levels of transaminases (e.g., ALT and AST) indicate damage to cell
membranes and may be evidence of widespread liver dysfunction.(31) As expected, APAP
overdose caused an average elevation in circulating ALT of >200-fold, and an elevation in AST of
-100-fold, compared with controls. However, pretreatment with sulforaphane attenuated the
increase in transaminases. On average, sulforaphane-treated mice had roughly half the
transaminase activity of mice that did not receive sulforaphane (Fig. 2). Transaminase data was
paralleled by hepatic histology, as assessed by hematoxylin and eosin staining (Fig. 3A). APAP
caused necroinflammatory liver damage at pericentral regions of the liver in all mice, but the size
of the necrotic areas was visibly diminished by SFN. APAP overdose also caused an increase in
hemorrhagic necrosis, which is seen after chloroacetate esterase staining as an infiltraticrh of red
blood cells into necrotic areas (Fig. 38). SFN reduced the extravasation of red blood cells from
pericentral foci, consistent with the observed changes in ALT, AST, and cellular morphology.

SFN decreased indices of oxidative stress
Glutathione is the first line of defense against APAP toxicity(32): APAP's toxic metabolite
NAPQI is primarily removed by conjugation with GSH. In an experiment comparing the effects of
SFN alone to control treatment, SFN was found to increase total hepatic glutathione (>1.2x on
average; Fig. 4). A similar effect on glutathione was seen after APAP overdose. In control mice
that were fasted overnight, glutathione content was measured at -3400 nmol/gram of tissue.
After APAP injection, glutathione was reduced by half (-1500 nmol/g). With previous SFN
administration, however, glutathione depletion was blunted (-2500 nmol/g) (Fig. 5, GSH+GSSG).
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Glutathione reductase activity was also significantly reduced by APAP. Enzyme activity
in control mice averaged 35 units/g protein, but APAP overdose reduced this activity to -27 U/g.
SFN pretreatment maintained the catalytic activity of GR at 35 U/g even after APAP (Fig. 5, GR).
Lipid peroxidation strongly correlates with the availability of glutathione.(33; 34) As expected, the
lipid peroxidation product 4-hydroxynonenal was detected over a substantial area of liver tissue
after APAP intoxication (Fig. 6). Though the characteristic brown stain indicating membrane lipid
oxidation was present in all animals after APAP injection, this staining was more diffuse in mice
that were pretreated with SFN. Lipid peroxidation, like necrosis, was largely confined to
pericentral areas of the liver.

SFN did not inhibit CYP2E1, but induced Nrf2
The microsomal drug-metabolizing enzyme Cytochrome P450 2E1 (CYP2E1), found
abundantly in the liver, is the primary P450 isozyme involved in NAPQI formation.
Correspondingly, many of the substances that prevent APAP intoxication work by inhibiting
CYP2E1 and therefore reducing the formation of NAPQI. At this dose of SFN, however, no
inhibition of CYP2E-1 was observed (Fig. 7). The average activity of CYP2E1 protein in watertreated mice was 0.57 nmol/mg/min. In comparison the average CYP2E1 activity of SFN-treated
mice was 0.54 nmol/mg/min, which was not statistically different.
Though SFN had no apparent effect on CYP2E1, it caused a robust increase in Nrf2
protein (Fig. 8). Six hours after SFN treatment, Nrf2 was present in both nuclear and cytosolic
cell fractions at levels roughly 2x greater than control. The ratio of nuclear Nrf2 to cytosolic Nrf2
was unaffected by treatment.

SFN did not significantly increase the mRNA levels of antioxidant genes
Because Nrf2 is a transcription factor for antioxidant-related genes, the mRNA levels of
such genes should indirectly indicate the presence of Nrf2 in the nucleus. Two well-studied
antioxidant genes were chosen as potential representatives of increased nuclear localization:
heme oxygenase 1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (Nq01).
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Six hours after SFN there is an apparent trend toward increased transcription of Nqo1
and HO-1. This trend is not observed at 24 hours after SFN. At neither time was there a
significant difference in transcription between treated subjects and controls.
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DISCUSSION

Oxidative stress is a known mediator of several pathologies, such as drug-induced liver
failure. In spite of this, it has been shown that compounds that directly interact with oxidant
species are often ineffective, and at times may worsen clinical outcomes. Sulforaphane was
used here to investigate the ability of indirect antioxidants to prevent liver injury due to
acetaminophen overdose. In contrast to direct antioxidants, SFN prevented liver damage and
decreased the levels of several biomarkers for oxidative stress.
As explained in the Introduction, SFN is hypothesized to act through Nrf2, a transcription
factor for antioxidant genes. The immunoblot data presented here support this hypothesis. After
SFN administration, Nrf2 levels increased in both the nucleus and the cytoplasm. The increase in
nuclear Nrf2 may be due to SFN's purported ability to induce conformational change in Keap1,
which would allow Nrf2 to move into the nucleus for the purposes of DNA binding. Additionally,
the increase in cytosolic Nrf2 supports the finding of Purdom-Dickinson et al. that enhanced
translation of Nrf2 is a central feature of the antioxidant response.(35)
In parallel to its direct effect on Nrf2, SFN acted on some of the downstream targets of
the transcriptional pathway. Mice treated with SFN had substantial augmentation of total cellular
glutathione and glutathione reductase activity. These same mice were also protected from liver
injury. Implied here is a specific, Nrf2-mediated mechanism by which SFN was protective.
Maintenance of cellular thiols is especially important after acetaminophen overdose. SFN-treated
animals maintained total cellular glutathione better than untreated animals; therefore, they were
better able to remove the toxic APAP metabolite NAPQI before it could cause more extensive
hepatic damage.
It must be noted that SFN, for all of its effects on Nrf2 and Nrf2's downstream targets, did
not appear to influence mRNA levels of the antioxidant genes Nqo 1 and HO-1. The reason for
this is not immediately clear and might be attributed to several variables. Response to SFN has
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been shown to differ according to species, target tissue, dose, and method of administration.
Thimmulappa et al. reported an increase in hepatic Nq01 mRNA after giving SFN i.g. at a dose of
9 ~mol/mouse/day x 7 days. (36) Robbins et al. reported no such increase in mRNA after 2 weeks
of feeding a standardized diet which provided a dose of 18.96 ~mol total glucosinolates/day.(37)
The dose chosen for this experiment - 10 mg/kg/day - is in between those chosen by
Thimmulappa and Robbins, being equivalent to 56.4

~mol/kg/day.

Due to the different times and

routes of administration used in each study, however, it is difficult to extrapolate a cause for the
variation in Nq01 mRNA levels. Furthermore, at this time there are no published studies of
hepatic mRNA expression using SFN at or near 10 mg/kg. In the future it will be necessary to test
a wider assortment of genes over a range of doses so that SFN's effects on gene expression may
be better characterized.
Taken together, the results of this study indicate that SFN prevents acute liver injury after
acetaminophen overdose. Specifically, SFN protected the liver by preventing the oxidative stress
that invariably precedes APAP-induced hepatic failure. The data presented here support the role
of alleviation of oxidative stress in APAP overdose and suggest a potential role for indirect
antioxidants in clinical practice.
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SUMMARY AND CONCLUSIONS

APAP overdose is the leading cause of fulminant hepatic failure,(38) yet there are few
viable approaches to treating or preventing APAP-related liver injury. The FDA's approval in 1985
of oral n-acetylcysteine (NAC) remains an important medical breakthrough, but aside from the
introduction of an injectable form of NAC in 2004, there have been no new drugs specifically
indicated for APAP overdose in over 20 years. Meanwhile, the incidence of APAP-related toxicity
shows no signs of decline,(39; 40) so there is still a need for new and innovative therapies.
One potential new therapy for APAP toxicity is the use of Nrf2 inducers. Numerous
studies, several of which are referenced in this text, identify Nrf2 induction as a critical mediator of
drug and xenobiotic metabolism. The experiments described here build on those earlier studies
by demonstrating the application of the Nrf2 inducer SFN in a model of APAP overdose. The
fundamental goal of this work was to determine the potential toxicologic utility ofNrf2 inducers
such as SFN.
At this time there is no established protocol for administration of Nrf2 inducers in cases of
liver injury. The ultimate development of new therapies for APAP-induced hepatic failure will
require extensive additional research. These data, however, represent a small step toward the
realization of a new approach to a widespread and costly public health problem. By
demonstrating the efficacy of sulforaphane in vivo, this work provides further proof of concept for
an Nrf2-based approach to APAP-induced liver injury.
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Fig. 2: Effect of acetaminophen and sulforaphane on plasma parameters
Male C57BU6J mice were pretreated with water or sulforaphane for 4 days and
injected with APAP or saline vehicle on day 5 as described in Methods. The
plasma ALT and AST levels were analyzed. Data are means ± SEM (n = 4-6).
ap<O.05 compared to saline injection; bp<O.05 compared to APAP alone.
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Fig. 3: Effect of acetaminophen and sulforaphane on hepatic ultrastructure

Representative photomicrographs (200x) of hematoxylin and eosin (panel A) and
chloroacetate esterase (panel 8) are shown. Inflammation and coagulative
necrosis of pericentral regions is observable in the APAP-treated groups.

15

8000 -y-----------------,

a

GSH
CI)

:::s

6000

tn
tn

.-.....
D)

E

4000

-

........

0

E

c

2000

o

-L..-_

Fig. 4: Effect of SFN on total hepatic glutathione
Male C57BU6J mice were pretreated with water or SFN for 4 days and sacrificed
6h after last treatment, as described in Methods. Total glutathione was
determined by spectrophotometry. Data are means ± SEM (n = 4). ap <O.05
compared to water alone

16

4000

GSH + GSSG

(1)

::l

tn

3000

.-....tn
0')

--

E
o

2000

E

c

1000

0

-

40

.-c
....0

GR

(1)

30

"C-

-.O')

: :l

20

~

>

~

U

«

10

0

APAP
SFN

+
+

+
+

Fig. 5: Effect of APAP and SFN on glutathione content and synthesis
Hepatic levels of total glutathione and glutathione reductase activity were
determined by spectrophotometry. Data are means ± SEM (n = 4). ap <O.05
compared to saline injection; bp <O.05 compared to APAP alone

17

Water

SFN

Fig. 6: Effect of APAP and SFN on membrane lipid peroxidation
Adducts of 4-hydrox¥nonenal were detected by immunohistochemistry as
described previously. (1 )
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Activity of the microsomal enzyme CYP2E 1 was determined by observing the
conversion of p-nitrophenol to 4-nitocatechol. Data are reported as means ± SEM
(n = 4).

19

Water
j],f

~

Nrf2 • nuclear

SFN

~ 7t»HT~

~

-!0,.ii!

Nrf2 - cytosolic

r

t

_

i

GAPDH

1.0

ec:

-

Nrf2
a

0.8

0

0.6

0

0.•

()

"0

'0

11-

0 ..2

0.0

0

;::

1.4

0::

1.2

to

(,)

Water

SFN

Water

SFN

Nrf2

1.0

0

en

0

~

0.8

()

0.6

-...
0

0.4

to

0.2

:s

0.0

.!
(,)
Z

Fig. 8: Nuclear accumulation of Nrf2
Male C57BLl6J mice were treated with water or SFN alone and immunoblots
were performed as described in Methods. Representative immunoblots for Nrf2
at the 6 h time point are shown (top panel). Nrf2 protein levels were normalized
to loading controls and quantified by densitometry (bottom panels).

20

REFERENCES
1. Kong A-NT, Owuor E, Yu R, Hebbar V, Chen C, Hu R, Mandlekar S. Induction of xenobiotic
enzymes by the map kinase pathway and the antioxidant or electrophile response element
(ARE/EpRE). Drug Metab Rev 2001 ;33:255-271 .
2. Takakusa H, Masumoto H, Mitsuru A, Okazaki 0 , Sudo K. Markers of Electrophilic Stress
Caused by Chemically Reactive Metabolites in Human Hepatocytes. Drug Metab Dispos
2008;36:816-823.
3. Malhi H, Giucciardi ME, Gores GJ . Hepatocyte Death : A Clear and Present Danger. Physiol
Rev 2010;90:1165-1194.
4. Sies H. Oxidative Stress: Oxidants and Antioxidants. Exp PhysioI1997;82:291-295.
5. Szeto HH. Cell-permeable, Mitochondrial-targeted, Peptide Antioxidants. AAPS J
2006;8:E277 -E283.
6. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology
2003;124:778-790.
7. Paolini M, Pozzetti L, Pedulli GF, Marchesi E, Cantelli-Forti G. The Nature of Prooxidant
Activity of Vitamin C. Life Sci 1999;64:273-278.
8. Herbert V. Prooxidant Effects of Antioxidant Vitamins. American Institute of Nutrition J Nutr
1996;126: 1197S-1200S.
9. Miller ER3, Pastor-Barriuso R, Dalal D, Riemersma R, Appel LJ , Guallar E. Meta-analysis:
high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med
2005;142:37-46.
10. Podmore I, Griffiths H, Herbert K, Mistry N, Mistry P, Lunec J. Vitamin C exhibits prooxidant properties. Nature 1998;392:559.
11 . Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of
cytoprotective proteins. Mol Nutr Food Res 2008;52 :S128-S138.
12. Fimognari C, Lenzi M, Hrelia P. Interaction of the Isothiocyanate Sulforaphane with Drug
Disposition and Metabolism: Pharmacological and Toxicological Implications. Curr Drug
Metab 2008;668-678.
13. Hu R, Hebbar V, Kim B-R, Chen C, Winnik B, Buckley B, Soteropoulos P, Tolias P, Hart
RP, Kong A-NT. In Vivo Pharmacokinetics and Regulation of Gene Expression Profiles by
Isothiocyanate Sulforaphane in the Rat. J Pharmacol Exp Ther 2004;310:263-271 .
14. Kobayashi A, Kang M-I , Watai Y, Tong KI, Sh ibata T, Uchida K, Yamamoto M. Oxidative
and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of
Keap1 . Mol Cell Bioi 2006;26:221-229.

21

15.

Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H, Yamamoto
M. Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2
Activity. Mol Cell Bioi 2008;28:2758-2770.

16. Rushmore TH , Morton MR, Pickett CB. The Antioxidant Responsive Element. Journal of
Biological Chemistry 1991 ;266: 11632-11639.
17. Nguyen T, Nioi P, Pickett CB. The Nrf2-Antioxidant Response Element Signaling Pathway
and Its Activation By Oxidative Stress. J Bioi Chem 2009;284:13291-13295.
18. Juge N, Mithen RF, Traka M. Molecular basis for chemoprevention by sulforaphane: a
comprehensive review. Cell Mol Life Sci 2007;64:1105-1127.
19. Ahn Y-H , Hwang Y, Liu H, Wang XJ , Zhang Y, Stephenson KK, Boronina TN , Cole RN,
Dinkova-Kostova AT, Talalay P, Cole PA. Electrophilic tuning of the chemoprotective
natural product sulforaphane. Proc Natl Acad Sci 2010; 107:9590-9595.
20. Jaeschke H. Glutathione Disulfide Formation and Oxidant Stress during AcetaminophenInduced Hepatotoxicity in Mice in Vivo: The Protective Effect of Allopurinol. J Pharmacol
Exp Ther 1990;255:935-941 .
21 . Hinson JA, Pumford NR, Roberts OW. Mechanisms of Acetaminophen Toxicity:
Immunochemical Detection of Drug-Protein Adducts. Drug Metab Rev 1995;27 :73-92.
22 . Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in druginduced hepatotoxicity. Curr Med Chem 2009;16:3041-3053.
23 . McKim SE, Konno A, Gabele E, Uesugi T, Froh M, Sies H, Thurman RG, Arteel GE. Cocoa
extract protects against early alcohol-induced liver injury in the rat. Arch Biochem Biophys
2002 ;406:40-46.
24. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and
glutathione disulfide levels using enzymatic recycling method . Nat Protoc 2007;1:31593165 .
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of
protein utilizing the principle of protein-dye binding . Anal Biochem 1976;72 :248-254.
26. Cox B, Emili A. Tissue subcellular fractionation and protein extraction for use in massspectrometry-based proteomics. Nat Protoc 2006; 1: 1872-1878.
27. Falkner KC , McCallum GP, Cherian MG, Bend JR. Effects of acute sodium arsenite
administration on the pulmonaryu chemical metabOlizing enzymes, cytochrome P-450
monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase
in guinea pig : comparison with effects in liver and kidney. Chem Bioi Interact 1993;86:5168.
28. Chang TKH , Crespi CL, Waxman OJ . Spectrophotometric Analysis of Human CYP2E1Catalyzed p-Nitrophenol Hydroxylation. In: Ph illips IR and Shephard EA, eds. Cytochrome
P450 Protocols. Totowa, NJ: Humana Press, 1998:147-152.
29. All is JW, Robinson BL. A Kinetic Assay for p-N itrophenol Hydroxylase in Rat Liver
Microsomes. Anal Biochem 1994;219:49-52.

22

30. Dignam JD, Lebovitz RM , Roeder RG. Accurate transcription initiation by RNA polymerase
II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11 :14751489.
31 . James LP, Mayeux PR, Hinson JA. Acetaminophen-Induced Hepatotoxicity. Drug Metab
Dispos 2003;31 :1499-1506.
32 . Jaeschke H, Knight TR, Bajt ML. The role of oxidant stress and reactive nitrogen species in
acetaminophen hepatotoxicity. Toxicol Lett 2003;144:279-288.
33. Romero FJ , Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Marin N, Roma J. Lipid
Peroxidation Products and Antioxidants in Human Disease. Environ Health Perspect
1998;106: 1229-1234.
34 . Meydani SN , Wu 0 , Santos MS, Hayek MG. Antioxidants and immune response in aged
persons: overview of present evidence. Am J Clin Nutr 1995;62 :1462S-1476S.
35. Purdom-Dickinson SE, Sheveleva EV, Sun H, Chen OM . Translational Control of Nrf2
Protein in Activation of Antioxidant Response by Oxidants. Mol PharmacoI2007 ;72 :10741081 .
36. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification
of Nrf2-regulated Genes Induced by the Chemopreventive Agent Sulforaphane by
Oligonucleotide Microarray. Cancer Res 2002 ;62 :5196-5203.
37. Robbins MG, Hauder J, Somoza V, Eshelman BD, Barnes OM , Hanlon PRo Induction of
Detoxification Enzymes by Feeding Unblanched Brussels Sprouts Containing Active
Myrosinase to Mice for 2 Wk. J Food Sci 2010;75:H190-H199.
38. Chun L, Tong MJ , Busuttil RW, Hiatt JR. Acetaminophen Hepatoxicity and Acute Liver
Failure. J Clin Gastroenterol 2009;43:342-349 .
39.

Fontana RJ, Adams PC. "Unintentional" acetaminophen overdose on the rise: Who is
responsible? Can J GastroenteroI2006;20:319-324.

40.

Hersh EV, Pinto A, Moore PA. Adverse Drug Interactions Involving Common Prescription
and Over-the-Counter Analgesic Agents. Clin Ther 2007;29 Suppl :2477-2497.

23

CURRICULUM VITAE
ROBIN H. SCHMIDT

Date of Birth:

June 15, 1984

Email address:

rhschm01 @Iouisville.edu

EDUCATION

Master of Science, Pharmacology and Toxicology
University of Louisville, Louisville, KY

2011 (anticipated)

Bachelor of Science, Funeral Services
St. John's University, Jamaica, NY

2006

Association in Occupational Studies, Funeral Services
American Academy McAllister Institute, New York, NY

2006

HONORS

2002 - 2006
Merit Scholarship, St. John's University
2002 - 2006
Dean's List, St. John's University
2006
Board of Trustees Award, American Academy McAllister Institute
2008 - present
Graduate Research Fellowship, Integrated Programs in Biomedical Sciences
2010
Best Platform Presentation , Ohio Valley Society of Toxicology

PROFESSIONAL SOCIETIES AND MEMBERSHIPS

2003
Phi Eta Sigma Honor Society
2006
Mu Sigma Alpha Honor Society

24

2006
National Board Certification in Funeral Directing and Embalming
2010
New York Academy of Sciences
2010
Kentucky Academy of Science
2010
University of Louisville Academic Grievance Committee

ABSTRACTS

Baldauf KJ , Schmidt RH , Ding X, Beier JI , Tan M, and Arteel GE (2010) Sulforaphane Enhances
Liver Regeneration after Partial Hepatectomy in Mice. Hepatology 52 :617A
Schmidt RH , Falkner KC, Beier J, and Arteel G (2011) Sulforaphane Prevents AcetaminophenInduced Hepatic Injury in Mice. The Toxicologist 120:99
Tan M, Schmidt RH , Zhong H, States J, and Arteel GE (2011) Chronic Low-Dose Arsenic
Exposure Enhances Hepatic Injury Induced by High Fat Diet in Mice. The Toxicologist 120:429

PRESENTATIONS

OS/2009
Research Seminar - "Effects of Rapamycin on Hepatic Steatosis Caused by Ethanol"
University of Louisville Seminar in Pharmacology and Toxicology
Louisville, KY
09/2010
Presentation - "Sulforaphane prevents acetaminophen-induced hepatic injury in mice"
Ohio Valley Society of Toxicology Annual Meeting
Cincinnati , OH
10/2010
Poster Presentation - "Sulforaphane prevents acetaminophen-induced hepatic injury in mice"
Research ! Louisville
Lou isville, KY
03/2011
Poster Presentation - "Sulforaphane prevents acetaminophen-induced hepatic injury in mice"
Society of Toxicology Annual Meeting
Washington , DC

25

